“That’s a huge knowledge gap.” — Peter Nelson, MD, PhD, of the Sanders-Brown Center on Aging at the University of Kentucky, on the limited ways to detect a new Alzheimer’s-like brain disorder.
“It’s a kind of extortion.” — Cancer patient Evalyn Bodick, commenting on a legal dispute between two large health systems and its potential impact on out-of-pocket healthcare costs.
“I think it’s kind of a watershed moment in how we’ll look at the treatment of this disease.” — Raymond Douglas, MD, PhD, of Cedars Sinai Medical Center in Los Angeles on a novel thyroid eye disease therapy.
“It’s important to work across the aisle because you can actually get stuff done.” — Charlotte Pineda, healthcare adviser to Rep. Roger Marshall, MD, on a bipartisan effort to develop legislation addressing prior authorization.
“These aren’t wildly expensive or difficult kinds of interventions.” — Francis Sessions Cole III, MD, of Washington University in St. Louis, on ways to avoid exposing infants to secondhand smoke.
“This is not just a program where numbers are shifted around; the numbers apply to people, to human beings.” — Rep. Anna Eshoo (D-Calif.), on Medicare drug pricing.
“We are troubled that this product is going into the market with a lot of questions remaining.” — Erika Sward, MA, of the American Lung Association, commenting on the FDA decision to allow limited sales of heat-not-burn tobacco devices.
“Hence, our findings are applicable to a clinical endocrinologist practicing anywhere, and translation into practice is possible immediately.” — Shobana Athimulam, MBBS, of the Mayo Clinic in Rochester, Minnesota, on using steroid markers to accurately predict adrenocortical carcinoma.